5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow Healthy Male Volunteer: new trials by email Literature Review of Healthy Male Volunteer trials Research Report on Healthy Male Volunteer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers Telmisartan, Amlodipine, Rosuvastatin - Healthy Male Volunteer | Phase 1 | Completed | Yuhan Corporation | 60 | 2014-07-01 | 2015-02-18 |
| A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers Exforge®, G-0081 - Healthy Male Volunteer | Phase 1 | Completed | Dong-A Pharmaceutical Co., Ltd. | 51 | 2012-07-01 | 2013-01-25 |
| A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam JNJ-38518168 (30 mg), JNJ-38518168 (10 mg), JNJ-38518168 (3 mg) - Healthy Male Volunteer | Phase 1 | Completed | Janssen Research & Development, LLC | 94 | 2011-09-01 | 2013-03-04 |
| The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea CKD-501 0.5 mg tablet, Glimepiride 4 mg tablet, CKD-501 placebo tablet, Glimepiride 4 mg tablet - Healthy Male Volunteer | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2010-05-01 | 2010-12-10 |
| AZD1981 Midazolam CYP4503A Induction Study AZD1981, Midazolam - Healthy Male Volunteer | Phase 1 | Completed | AstraZeneca | 28 | 2009-03-01 | 2009-04-10 |
Midazolam (2) · AZD1981 (1) · Amlodipine (1) · Amlodipine, Valsartan Drug Combination (1) · Rosuvastatin Calcium (1) · Tablets (1) · Telmisartan (1) · glimepiride (1) · lobeglitazone (1)
AstraZeneca (1) · Chong Kun Dang Pharmaceutical (1) · Dong-A Pharmaceutical Co., Ltd. (1) · Janssen Research & Development, LLC (1) · Yuhan Corporation (1)
South Korea (2) · Sweden (1) · United States (1)
Aslak Rautio (1) · Eva Pettersson (1) · Ji Young Park, Ph.D. (1) · K S Park, MD, PhD (1) · Minkgyu Park, Ph.D, M.D. (1)